Fresh from Epirus dis­as­ter, Mun­shi chops staff to re­make Are­na Phar­ma

A new ax cuts the deep­est. And new Are­na Phar­ma­ceu­ti­cals $AR­NA CEO Amit Mun­shi is us­ing his shiny blade to whit­tle the com­pa­ny down to fit his pro­file of a lean, mean, drug de­vel­op­ment ma­chine — even as his old com­pa­ny Epirus strug­gles to sur­vive.

With com­pa­ny co-founder Jack Lief long gone af­ter the mis­er­able de­but of weight loss drug Belviq, Mun­shi is get­ting back to ba­sics. And he’s cut­ting 100 staffers in the process — 73% of the re­main­ing U.S. staff, which had al­ready had its ranks thinned in an ear­li­er re­struc­tur­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER